GreenLight Biosciences settlements

GreenLight Biosciences is the subject of a $2,000,000 securities class action settlement stemming from its 2023 merger, in which shareholders received $0.30 per share when the deal closed on July 24, 2023. Record and beneficial holders of GreenLight Biosciences Holdings, PBC common stock who held shares during the tender offer period of June 21 through July 20, 2023 may be eligible for approximately $0.04 per share after deductions, subject to a $10 minimum payment threshold. The verified claim deadline is July 29, 2026 — proof of your shareholding is required.

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

False Advertising

GreenLight Biosciences Merger $2M Securities Settlement

Greenlight Biosciences Holdings, PBC settled a securities lawsuit over the terms of its 2023 merger, in which shareholders' stock was exchanged for $0.30 per share. The company agreed to a $2 million fund for shareholders who held stock during the June 21 to July 20, 2023 tender offer period. The claim filing window closed on July 29, 2026.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements